The CEA/SCC/CYFRA21-1/NSE/proGRP Detection Kit is a state-of-the-art diagnostic tool designed for the precise and efficient detection of multiple tumor markers in human serum. Utilizing flow fluorescence luminescence technology, this kit offers high sensitivity and specificity, making it an essential tool in oncology diagnostics.
1. The kit is characterized by its high sensitivity and specificity, ensuring accurate detection of tumor markers even at low concentrations. Its advanced flow fluorescence luminescence method allows for simultaneous detection of multiple biomarkers, reducing the time and cost associated with separate tests.
2. The kit is composed of three main components: Capture Microsphere Suspension, Fluorescently Labeled Antibodies, and Calibrators. Each component is meticulously formulated to ensure optimal performance, with precise concentrations of antibodies, antigens, and stabilizers.
3. The primary use of this kit is in the field of oncology, where it aids in the monitoring of tumor treatment efficacy, prognosis assessment, and early detection of recurrence. Its ability to detect multiple markers simultaneously makes it a valuable tool for comprehensive cancer management.
The CEA/SCC/CYFRA21-1/NSE/proGRP Detection Kit, also known as the Tumor Marker Detection Kit, is a versatile and reliable diagnostic tool. Its advanced technology and comprehensive approach to tumor marker detection make it an indispensable asset in modern oncology.
The main features of this kit include high sensitivity, specificity, and the ability to detect multiple tumor markers simultaneously. Its advanced flow fluorescence luminescence technology ensures accurate and reliable results.
1. High Sensitivity: The kit is designed to detect tumor markers at very low concentrations, ensuring early and accurate diagnosis.
2. Multi-Marker Detection: It can simultaneously detect five different tumor markers, reducing the need for multiple tests and saving time.
3. Advanced Technology: The use of flow fluorescence luminescence technology enhances the accuracy and reliability of the results.
4. Comprehensive Components: The kit includes all necessary components, such as capture microspheres, fluorescently labeled antibodies, and calibrators, ensuring optimal performance.
5. User-Friendly: The kit is designed for ease of use, with clear instructions and minimal preparation required.
The CEA/SCC/CYFRA21-1/NSE/proGRP Detection Kit stands out for its high sensitivity, multi-marker detection capability, and advanced technology. Its comprehensive components and user-friendly design make it a top choice for oncology diagnostics.
This kit is widely used in clinical settings for the detection and monitoring of tumor markers. It plays a crucial role in oncology diagnostics, aiding in treatment efficacy monitoring, prognosis assessment, and recurrence detection.
1. Treatment Efficacy Monitoring: The kit is used to monitor the effectiveness of cancer treatments by tracking changes in tumor marker levels over time.
2. Prognosis Assessment: It helps in assessing the prognosis of cancer patients by providing insights into the progression of the disease.
3. Recurrence Detection: Early detection of tumor recurrence is possible with this kit, allowing for timely intervention.
4. Comprehensive Cancer Management: The ability to detect multiple markers simultaneously aids in the comprehensive management of cancer patients.
5. Research and Development: The kit is also used in research settings to study the role of various tumor markers in cancer progression and treatment.
The CEA/SCC/CYFRA21-1/NSE/proGRP Detection Kit is a vital tool in clinical oncology. Its applications range from treatment monitoring to prognosis assessment and recurrence detection, making it an essential component of comprehensive cancer care.
When purchasing this kit, it is important to consider product specifications, types, budget, and intended use. Understanding these factors will help in making an informed decision.
1. Product Specifications: Ensure that the kit meets the required specifications for sensitivity, specificity, and detection range.
2. Product Types: There may be different versions of the kit available, so choose the one that best fits your needs.
3. Budget: Consider the cost of the kit and ensure it fits within your budget while still meeting your requirements.
4. Intended Use: Determine the specific applications for which you will be using the kit, such as clinical diagnostics or research.
Purchasing the CEA/SCC/CYFRA21-1/NSE/proGRP Detection Kit requires careful consideration of product specifications, types, budget, and intended use. By understanding these factors, you can make an informed decision that best suits your needs.
Proper handling and storage of the kit are essential to ensure accurate results. Follow all instructions carefully and be aware of potential hazards.
1. Storage Conditions: Store the kit at the recommended temperature to maintain the stability of the components.
2. Handling: Handle all components with care to avoid contamination and ensure accurate results.
3. Safety Precautions: Wear appropriate protective equipment when handling the kit, especially when dealing with biological samples.
4. Expiration Date: Always check the expiration date before use to ensure the kit is still effective.
5. Disposal: Dispose of all components according to local regulations to avoid environmental contamination.
The CEA/SCC/CYFRA21-1/NSE/proGRP Detection Kit requires careful handling and storage to ensure accurate results. By following the recommended precautions, you can minimize risks and maximize the effectiveness of the kit.
We have the latest medical device product database in China, which can quickly meet your procurement needs.
Submit your purchase list, and we will reply to your inquiry within half an hour at the earliest.